(ACB) Aurora Cannabis - Performance -26.3% in 12m
ACB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-86.77%
#176 in Peer-Group
Rel. Strength
20.46%
#6114 in Stock-Universe
Total Return 12m
-26.27%
#138 in Peer-Group
Total Return 5y
-96.22%
#175 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 20.4 |
| P/E Forward | 102 |
| High / Low | USD |
|---|---|
| 52 Week High | 7.05 USD |
| 52 Week Low | 3.46 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 46.46 |
| Buy/Sell Signal +-5 | 0.46 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ACB (-26.3%) vs XLV (-8.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.72% | 121% | 333% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
1.34% | 12.4% | 75.7% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-4.44% | -18.3% | 393% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.32% | 0.4% | 50.2% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.59% | 2.11% | 42.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.6% | -9.78% | 100% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| IPN PA Ipsen |
0.96% | -4.39% | 39.9% | 25.8 | 10.4 | 0.74 | -6.40% | -6.33% |
| UCB BR UCB |
5.4% | 19.5% | 57.7% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: ACB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ACB
| Total Return (including Dividends) | ACB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -26.99% | -1.83% | 3.54% |
| 3 Months | 6.15% | -3.24% | 16.07% |
| 12 Months | -26.27% | -8.73% | 12.18% |
| 5 Years | -96.22% | 35.53% | 107.69% |
| Trend Score (consistency of price movement) | ACB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.1% | 35.5% | 91.4% |
| 3 Months | -3% | -14.5% | 97.5% |
| 12 Months | -47.1% | -79.5% | 46.7% |
| 5 Years | -91.1% | 87.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th3.50 | -25.63% | -29.49% |
| 3 Month | %th37.50 | 9.70% | -8.55% |
| 12 Month | %th32.50 | -19.22% | -34.27% |
| 5 Years | %th12.50 | -97.21% | -98.18% |
FAQs
Does Aurora Cannabis (ACB) outperform the market?
No,
over the last 12 months ACB made -26.27%, while its related Sector, the Health Care Sector SPDR (XLV) made -8.73%.
Over the last 3 months ACB made 6.15%, while XLV made -3.24%.
Performance Comparison ACB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ACB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.8% | -30.5% | 7.5% | -38% |
| US NASDAQ 100 | QQQ | -2.3% | -31.3% | 5.1% | -39% |
| German DAX 40 | DAX | -0.9% | -28.5% | -3.3% | -55% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.4% | -31.9% | 3.5% | -46% |
| Hongkong Hang Seng | HSI | -2.4% | -29.4% | -14.5% | -61% |
| India NIFTY 50 | INDA | -0.1% | -27.6% | 6.1% | -23% |
| Brasil Bovespa | EWZ | 2.8% | -24% | -4.6% | -27% |
ACB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.8% | -28.8% | 3.4% | -50% |
| Consumer Discretionary | XLY | -2.2% | -29.6% | 16.2% | -42% |
| Consumer Staples | XLP | 0% | -26.3% | 6.8% | -33% |
| Energy | XLE | 0.3% | -26.7% | 17.7% | -24% |
| Financial | XLF | -0.5% | -29.6% | 8% | -48% |
| Health Care | XLV | 0.2% | -25.2% | 18% | -18% |
| Industrial | XLI | -2.2% | -31.7% | 1.6% | -48% |
| Materials | XLB | 0.8% | -28.7% | 9.7% | -27% |
| Real Estate | XLRE | -1.3% | -26.4% | 8.7% | -33% |
| Technology | XLK | -2.2% | -33.3% | 1.7% | -37% |
| Utilities | XLU | -2.6% | -28.9% | 4.8% | -48% |
| Aerospace & Defense | XAR | -4.7% | -36.2% | -13.1% | -75% |
| Biotech | XBI | -3% | -30.1% | 16.1% | -12% |
| Homebuilder | XHB | -0.2% | -32.5% | 20.9% | -19% |
| Retail | XRT | -0.6% | -29.9% | 11.7% | -31% |
ACB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.7% | -22.8% | 23.9% | -20% |
| Natural Gas | UNG | -6.3% | -18.5% | 31.8% | -34% |
| Gold | GLD | -2.4% | -25.4% | -10.1% | -63% |
| Silver | SLV | -4.5% | -30.7% | -9.4% | -49% |
| Copper | CPER | -3.1% | -40.6% | -11.2% | -49% |
ACB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.4% | -26.8% | 13% | -22% |
| iShares High Yield Corp. Bond | HYG | -1.4% | -27.9% | 9.5% | -35% |